1. Home
  2. LRMR vs ANTA Comparison

LRMR vs ANTA Comparison

Compare LRMR & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • ANTA
  • Stock Information
  • Founded
  • LRMR N/A
  • ANTA 2022
  • Country
  • LRMR United States
  • ANTA Singapore
  • Employees
  • LRMR N/A
  • ANTA N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • ANTA Investment Bankers/Brokers/Service
  • Sector
  • LRMR Health Care
  • ANTA Finance
  • Exchange
  • LRMR Nasdaq
  • ANTA Nasdaq
  • Market Cap
  • LRMR 309.8M
  • ANTA 294.7M
  • IPO Year
  • LRMR N/A
  • ANTA 2025
  • Fundamental
  • Price
  • LRMR $3.96
  • ANTA $11.75
  • Analyst Decision
  • LRMR Strong Buy
  • ANTA Strong Buy
  • Analyst Count
  • LRMR 8
  • ANTA 2
  • Target Price
  • LRMR $17.88
  • ANTA $19.25
  • AVG Volume (30 Days)
  • LRMR 1.3M
  • ANTA 20.4K
  • Earning Date
  • LRMR 10-29-2025
  • ANTA 08-12-2025
  • Dividend Yield
  • LRMR N/A
  • ANTA N/A
  • EPS Growth
  • LRMR N/A
  • ANTA N/A
  • EPS
  • LRMR N/A
  • ANTA 0.24
  • Revenue
  • LRMR N/A
  • ANTA $56,997,910.00
  • Revenue This Year
  • LRMR N/A
  • ANTA $65.94
  • Revenue Next Year
  • LRMR N/A
  • ANTA $59.39
  • P/E Ratio
  • LRMR N/A
  • ANTA $48.43
  • Revenue Growth
  • LRMR N/A
  • ANTA 405.62
  • 52 Week Low
  • LRMR $1.61
  • ANTA $10.19
  • 52 Week High
  • LRMR $9.50
  • ANTA $27.72
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 54.10
  • ANTA N/A
  • Support Level
  • LRMR $3.78
  • ANTA N/A
  • Resistance Level
  • LRMR $4.26
  • ANTA N/A
  • Average True Range (ATR)
  • LRMR 0.27
  • ANTA 0.00
  • MACD
  • LRMR -0.00
  • ANTA 0.00
  • Stochastic Oscillator
  • LRMR 55.14
  • ANTA 0.00

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

Share on Social Networks: